Position in ARGX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,574,307
-$25,680,839 QoQ
Shares Held
13,111
-68.7% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Derivatives in ARGX
reported options exposure · as of Dec 31, 2024CallValue
$0
CallShares
0
PutValue
$492,000
PutShares
800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $2,350,910,046 across 177 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
1,665,102 | $221,008,988 | |
| 2 | INSM |
INSMED Inc
|
1,326,430 | $141,423,966 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,230,052 | $91,614,272 | |
| 4 | ABVX |
Abivax S.A.
|
603,840 | $80,467,718 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
145,005 | $72,028,333 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
2,016,379 | $63,032,007 | |
| 7 | CYTK |
Cytokinetics Inc
|
711,676 | $60,627,678 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
1,054,613 | $60,344,955 |
All Filings in ARGX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,574,307 | 13,111 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $35,255,146 | 41,923 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $49,221,741 | 89,296 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,703,803 | 9,637 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $492,000 | 800 | Put | Sole | 2025-02-14 | |
| 2024-09-30 | $271,040 | 500 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $7,137,567 | 13,167 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $596,288 | 1,100 | Put | Sole | 2024-11-14 | |
| 2024-06-30 | $19,422,326 | 45,164 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $22,460,151 | 57,046 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $62,920,458 | 165,393 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $45,346,476 | 92,237 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $62,168,950 | 159,518 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $36,335,864 | 97,525 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $26,679,102 | 70,425 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $33,953,524 | 96,172 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $52,473,743 | 138,497 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,631,436 | 17,860 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $3,881,908 | 12,854 | Shares | Sole | 2021-12-01 | |
| No filing history on record for this holder in this stock. | ||||||